• Mashup Score: 3

    15 February 2023 We’re working together with the British Association of Dermatologists to develop a new guideline for the management of people with Behçets. Behçets is a rare, multi-system, chronic, and recurrent inflammatory condition. The presentation is often insidious, typically characterised in the UK by recurrent oral and genital ulceration and…

    Tweet Tweets with this article
    • 🔜 Coming soon: New #Behçets guideline Professor Robert Moots, Consultant Rheumatologist and Co-chair of the Guideline Development Group shares his sentiments on the work in progress. Read more: https://t.co/JiLYubLUSN https://t.co/MffHXq58vI

  • Mashup Score: 1

    15 February 2023 We’re working together with the British Association of Dermatologists to develop a new guideline for the management of people with Behçet’s. Behçet’s (also known as Behçet’s disease or Behçet’s syndrome) is a rare, multi-system, chronic, and recurrent inflammatory condition. The presentation is often insidious, typically characterised in…

    Tweet Tweets with this article
    • 📝 We're excited to be working together with the British Association of Dermatologists (@HealthySkin4All) to develop a new guideline for the management of people with #Behçets disease. Read more about this guideline and clinical questions it will cover https://t.co/WpG631lWtJ https://t.co/6rdCQ0UqFL

  • Mashup Score: 0

    Sign up for our newsletter Yes please Privacy policy Thank you for getting in touch! Follow …

    Tweet Tweets with this article
    • 📝We're excited to be working together with the British Association of Dermatologists @HealthySkin4All to develop a new guideline for the management of people with #Behçets disease. Learn more about this guideline and the clinical questions it will cover https://t.co/YSE1f5dKWW https://t.co/J5S6MBRv1Y

  • Mashup Score: 0

    An OMERACT working group has developed and approved a core set of five domains — disease activity, new organ involvement, quality of life, adverse events and death — that are mandatory for study in all Behçet syndrome trials. “Although a number of trials have been conducted in [Behçet syndrome (BS)] with different agents, disease assessment has not been

    Tweet Tweets with this article
    • #OMERACT working group developed/approved a core set of 5 domains mandatory for study in all #Behcets Disease trials, noted researchers @istanbuledutr https://t.co/ea6tQ0wyVe